Fischer Medical Ventures Limited has informed the Exchange about Schedule of meet
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited has informed the exchanges about a scheduled earnings conference call with analysts and investors to discuss its financial results for the quarter ended September 30, 2025 (Q2 FY26) and H1 FY26. The virtual group meeting is fixed for Friday, November 7, 2025, at 12:00 PM IST. The call is being organised in association with Kirin Advisors and will feature Director Ms. Svetlana Rao, CFO Mr. Vivek Balasubramanian, COO Mr. Shankar Varadharajan, along with other management members. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during the call. Dial-in details and Diamond Pass registration links have been shared with investors.
This is a routine regulatory disclosure ahead of the company's quarterly results and is unlikely to move the stock on its own. However, it signals transparency and gives retail investors a chance to hear management's commentary on Q2 FY26 performance, which could shape near-term sentiment once results are formally announced.